These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4800219)

  • 21. Treatment of anemia in myeloproliferative disorders: a randomized study of fluoxymesterone v transfusions only.
    Brubaker LH; Brière J; Laszlo J; Kraut E; Landaw SA; Peterson P; Goldberg J; Donovan P
    Arch Intern Med; 1982 Aug; 142(8):1533-7. PubMed ID: 7103635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Agnogenic myeloid metaplasia. Natural history and treatment.
    Silverstein MN; Gomes MR; ReMine WH; Elveback LR
    Arch Intern Med; 1967 Nov; 120(5):546-50. PubMed ID: 6054588
    [No Abstract]   [Full Text] [Related]  

  • 23. [Transcobalamins in the diagnosis and treatment of myeloproliferative diseases].
    Rachmilewitz M; Rachmilewitz B
    Harefuah; 1976 May; 90(9):397-9. PubMed ID: 939448
    [No Abstract]   [Full Text] [Related]  

  • 24. Hemarthrosis as the presenting manifestation of myeloproliferative disease.
    Harris BK; Ross HA
    Arthritis Rheum; 1974; 17(6):969-70. PubMed ID: 4433355
    [No Abstract]   [Full Text] [Related]  

  • 25. [I-131 absorption in patients with polycythemia vera and change in this index after treatment by bloodletting and with P32].
    Shishkina VV; Suslina NG; Chebotareva ED
    Med Radiol (Mosk); 1968 Apr; 13(4):50-4. PubMed ID: 5658003
    [No Abstract]   [Full Text] [Related]  

  • 26. [The Soviet cytostatic preparation prospidin in the therapy of malignant reticulohemoblastosis].
    Kalamkarian AA
    Vestn Dermatol Venerol; 1978 Jun; (6):3-7. PubMed ID: 354247
    [No Abstract]   [Full Text] [Related]  

  • 27. [Aplastic syndrome in myleran overdose].
    Albrecht M; Tackmann W; Pribilla W
    Med Klin; 1971 Jan; 66(4):126-30. PubMed ID: 5278287
    [No Abstract]   [Full Text] [Related]  

  • 28. [The vascular manifestations of polycythemia].
    Viala JJ; Brun F; Chataing B
    Lyon Med; 1968 Jun; 219(23):1907-12 passim. PubMed ID: 5670634
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of alpha interferon and hydroxyurea in late phase refractory myeloproliferative disease.
    Litam PP; Landaw SA; Zamkoff KW
    Haematologia (Budap); 1994; 26(2):87-90. PubMed ID: 7890266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of thymoma in association with erythrocytosis.
    Sundström C
    Acta Pathol Microbiol Scand A; 1972; 80(2):235-40. PubMed ID: 5028053
    [No Abstract]   [Full Text] [Related]  

  • 31. The management of platelet disorders.
    Prankerd TA
    Proc R Soc Med; 1968 Jun; 61(6):603-4. PubMed ID: 5690850
    [No Abstract]   [Full Text] [Related]  

  • 32. [Familial Vaquez's diseases].
    Tursz T; Hakim J; Boivin P; Mallarmé J
    Presse Med (1893); 1971 Dec; 79(53):2427-32. PubMed ID: 5156526
    [No Abstract]   [Full Text] [Related]  

  • 33. [Combination of androgens and corticosteroids in the treatment of acquired bone marrow aplasias].
    Perugini S; Lusvarghi E; Vaccari G
    Schweiz Med Wochenschr; 1970 Nov; 100(46):1982-4. PubMed ID: 5507843
    [No Abstract]   [Full Text] [Related]  

  • 34. Myeloproliferative disorders: III. CML: Further studies on the role of cytogenetics in diagnosis, prognosis and management.
    Fuscaldo KE; Brodsky I; Kahn SB; Conroy JF; Marfurt K
    Haematologica; 1981 Aug; 66(4):461-88. PubMed ID: 6797881
    [No Abstract]   [Full Text] [Related]  

  • 35. Myelodysplasia and myeloproliferative disorders in childhood: an update.
    Emanuel PD
    Br J Haematol; 1999 Jun; 105(4):852-63. PubMed ID: 10554793
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical trials in myeloproliferative disorders: looking forward.
    Marchioli R; Finazzi G; Marfisi RM; Tognoni G; Barbui T
    Semin Hematol; 2005 Oct; 42(4):259-65. PubMed ID: 16210039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-CML myeloproliferative diseases. Preface.
    Levine RL
    Hematol Oncol Clin North Am; 2012 Oct; 26(5):xi. PubMed ID: 23009942
    [No Abstract]   [Full Text] [Related]  

  • 38. [Case of primary myelofibrosis].
    Matsuda M; Sasaki T; Nishiie K; Sampi K; Takazawa T
    Naika; 1969 Feb; 23(2):383-7. PubMed ID: 5783335
    [No Abstract]   [Full Text] [Related]  

  • 39. [The activity of the alkaline phosphatase of neutrophils in myeloproliferative diseases].
    Vakulenko AD; Shubich MG
    Ter Arkh; 1966 Feb; 38(2):66-9. PubMed ID: 5235224
    [No Abstract]   [Full Text] [Related]  

  • 40. [Etiopathogenetic and therapeutic criteria of shock in gravely injured subjects].
    Passaggio E; Calcagno A; Quercio M
    Pathologica; 1966; 58(867):523-8. PubMed ID: 4968468
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.